Literature DB >> 28572446

Histone deacetylase 1 activates PU.1 gene transcription through regulating TAF9 deacetylation and transcription factor IID assembly.

Wei Jian1, Bowen Yan1, Suming Huang2,3, Yi Qiu4.   

Abstract

Histone acetyltransferases and histone deacetylases (HDACs) are important epigenetic coregulators. It has been thought that HDACs associate with corepressor complexes and repress gene transcription; however, in this study, we have found that PU.1-a key master regulator for hematopoietic self-renewal and lineage specification-requires HDAC activity for gene activation. Deregulated PU.1 gene expression is linked to dysregulated hematopoiesis and the development of leukemia. In this study, we used erythroid differentiation as a model to analyze how the PU.1 gene is regulated. We found that active HDAC1 is directly recruited to active PU.1 promoter in progenitor cells, whereas acetylated HDAC1, which is inactive, is on the silenced PU.1 promoter in differentiated erythroid cells. We then studied the mechanism of HDAC1-mediated activation. We discovered that HDAC1 activates PU.1 gene transcription via deacetylation of TATA-binding protein-associated factor 9 (TAF9), a component in the transcription factor IID (TFIID) complex. Treatment with HDAC inhibitor results in an increase in TAF9 acetylation. Acetylated TAF9 does not bind to the PU.1 gene promoter and subsequently leads to the disassociation of the TFIID complex and transcription repression. Thus, these results demonstrate a key role for HDAC1 in PU.1 gene transcription and, more importantly, uncover a novel mechanism of TFIID recruitment and gene activation.-Jian, W., Yan, B., Huang, S., Qiu, Y. Histone deacetylase 1 activates PU.1 gene transcription through regulating TAF9 deacetylation and transcription factor IID assembly. © FASEB.

Entities:  

Keywords:  HDAC1; HDACi; TFIID; acetylation; downstream promoter element

Mesh:

Substances:

Year:  2017        PMID: 28572446      PMCID: PMC5572695          DOI: 10.1096/fj.201700022R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  70 in total

1.  DNA methylation and chromatin structure regulate PU.1 expression.

Authors:  L Amaravadi; M J Klemsz
Journal:  DNA Cell Biol       Date:  1999-12       Impact factor: 3.311

2.  mSin3A regulates murine erythroleukemia cell differentiation through association with the TAL1 (or SCL) transcription factor.

Authors:  S Huang; S J Brandt
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

Review 3.  PU.1: a crucial and versatile player in hematopoiesis and leukemia.

Authors:  Philippe Kastner; Susan Chan
Journal:  Int J Biochem Cell Biol       Date:  2007-02-04       Impact factor: 5.085

4.  Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells.

Authors:  N Rekhtman; F Radparvar; T Evans; A I Skoultchi
Journal:  Genes Dev       Date:  1999-06-01       Impact factor: 11.361

5.  The architecture of human general transcription factor TFIID core complex.

Authors:  Christoph Bieniossek; Gabor Papai; Christiane Schaffitzel; Frederic Garzoni; Maxime Chaillet; Elisabeth Scheer; Petros Papadopoulos; Laszlo Tora; Patrick Schultz; Imre Berger
Journal:  Nature       Date:  2013-01-06       Impact factor: 49.962

6.  Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1.

Authors:  P Zhang; G Behre; J Pan; A Iwama; N Wara-Aswapati; H S Radomska; P E Auron; D G Tenen; Z Sun
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

7.  Overexpression of PU.1 induces growth and differentiation inhibition and apoptotic cell death in murine erythroleukemia cells.

Authors:  T Yamada; N Kondoh; M Matsumoto; M Yoshida; A Maekawa; T Oikawa
Journal:  Blood       Date:  1997-02-15       Impact factor: 22.113

8.  A distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemia.

Authors:  Ulrich Steidl; Christian Steidl; Alexander Ebralidze; Björn Chapuy; Hye-Jung Han; Britta Will; Frank Rosenbauer; Annegret Becker; Katharina Wagner; Steffen Koschmieder; Susumu Kobayashi; Daniel B Costa; Thomas Schulz; Karen B O'Brien; Roel G W Verhaak; Ruud Delwel; Detlef Haase; Lorenz Trümper; Jürgen Krauter; Terumi Kohwi-Shigematsu; Frank Griesinger; Daniel G Tenen
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

9.  Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors.

Authors:  Stephen L Nutt; Donald Metcalf; Angela D'Amico; Matthew Polli; Li Wu
Journal:  J Exp Med       Date:  2005-01-17       Impact factor: 14.307

10.  Sustained PU.1 levels balance cell-cycle regulators to prevent exhaustion of adult hematopoietic stem cells.

Authors:  Philipp B Staber; Pu Zhang; Min Ye; Robert S Welner; César Nombela-Arrieta; Christian Bach; Marc Kerenyi; Boris A Bartholdy; Hong Zhang; Meritxell Alberich-Jordà; Sanghoon Lee; Henry Yang; Felicia Ng; Junyan Zhang; Mathias Leddin; Leslie E Silberstein; Gerald Hoefler; Stuart H Orkin; Berthold Göttgens; Frank Rosenbauer; Gang Huang; Daniel G Tenen
Journal:  Mol Cell       Date:  2013-02-08       Impact factor: 17.970

View more
  14 in total

1.  Transcriptional network regulation of the brassinosteroid signaling pathway by the BES1-TPL-HDA19 co-repressor complex.

Authors:  Hyemin Kim; Donghwan Shim; Suyun Moon; Jinsu Lee; Wonsil Bae; Hyunmo Choi; Kyunghwan Kim; Hojin Ryu
Journal:  Planta       Date:  2019-07-06       Impact factor: 4.116

2.  Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia.

Authors:  Sumiko Takao; Lauren Forbes; Masahiro Uni; Shuyuan Cheng; Jose Mario Bello Pineda; Yusuke Tarumoto; Paolo Cifani; Gerard Minuesa; Celine Chen; Michael G Kharas; Robert K Bradley; Christopher R Vakoc; Richard P Koche; Alex Kentsis
Journal:  Elife       Date:  2021-02-02       Impact factor: 8.713

3.  PU.1 regulates Alzheimer's disease-associated genes in primary human microglia.

Authors:  Justin Rustenhoven; Amy M Smith; Leon C Smyth; Deidre Jansson; Emma L Scotter; Molly E V Swanson; Miranda Aalderink; Natacha Coppieters; Pritika Narayan; Renee Handley; Chris Overall; Thomas I H Park; Patrick Schweder; Peter Heppner; Maurice A Curtis; Richard L M Faull; Mike Dragunow
Journal:  Mol Neurodegener       Date:  2018-08-20       Impact factor: 14.195

4.  Transcriptomic and Epigenomic Profiling of Histone Deacetylase Inhibitor Treatment Reveals Distinct Gene Regulation Profiles Leading to Impaired Neutrophil Development.

Authors:  Anita M A P Govers; Caroline R M Wiggers; Ruben van Boxtel; Michal Mokry; Edward E S Nieuwenhuis; Menno P Creyghton; Marije Bartels; Paul J Coffer
Journal:  Hemasphere       Date:  2019-08-07

Review 5.  H3K18Ac as a Marker of Cancer Progression and Potential Target of Anti-Cancer Therapy.

Authors:  Marta Hałasa; Anna Wawruszak; Alicja Przybyszewska; Anna Jaruga; Małgorzata Guz; Joanna Kałafut; Andrzej Stepulak; Marek Cybulski
Journal:  Cells       Date:  2019-05-22       Impact factor: 6.600

Review 6.  Role of HDACs in normal and malignant hematopoiesis.

Authors:  Pan Wang; Zi Wang; Jing Liu
Journal:  Mol Cancer       Date:  2020-01-07       Impact factor: 27.401

Review 7.  Regulating the Regulators: The Role of Histone Deacetylase 1 (HDAC1) in Erythropoiesis.

Authors:  Min Young Kim; Bowen Yan; Suming Huang; Yi Qiu
Journal:  Int J Mol Sci       Date:  2020-11-11       Impact factor: 5.923

Review 8.  The Role and Mechanism of Histone Deacetylases in Acute Kidney Injury.

Authors:  Xun Zhou; Hui Chen; Yingfeng Shi; Xiaoyan Ma; Shougang Zhuang; Na Liu
Journal:  Front Pharmacol       Date:  2021-06-16       Impact factor: 5.810

9.  Control of Maize Vegetative and Reproductive Development, Fertility, and rRNAs Silencing by HISTONE DEACETYLASE 108.

Authors:  Cristian Forestan; Silvia Farinati; Jacques Rouster; Hervé Lassagne; Massimiliano Lauria; Nicola Dal Ferro; Serena Varotto
Journal:  Genetics       Date:  2018-01-30       Impact factor: 4.562

10.  Enhanced osteopontin splicing regulated by RUNX2 is HDAC-dependent and induces invasive phenotypes in NSCLC cells.

Authors:  Jing Huang; Siyuan Chang; Yabin Lu; Jing Wang; Yang Si; Lijian Zhang; Shan Cheng; Wen G Jiang
Journal:  Cancer Cell Int       Date:  2019-11-21       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.